CALC
Price
$1.60
Change
+$0.04 (+2.56%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
21.94M
OBIO
Price
$2.90
Change
+$0.13 (+4.69%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
106.13M
Interact to see
Advertisement

CALC vs OBIO

Header iconCALC vs OBIO Comparison
Open Charts CALC vs OBIOBanner chart's image
CalciMedica
Price$1.60
Change+$0.04 (+2.56%)
Volume$252
Capitalization21.94M
Orchestra BioMed Holdings
Price$2.90
Change+$0.13 (+4.69%)
Volume$973
Capitalization106.13M
CALC vs OBIO Comparison Chart in %
Loading...
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CALC vs. OBIO commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CALC is a Hold and OBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (CALC: $1.58 vs. OBIO: $2.88)
Brand notoriety: CALC and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CALC: 173% vs. OBIO: 37%
Market capitalization -- CALC: $21.94M vs. OBIO: $106.13M
CALC [@Biotechnology] is valued at $21.94M. OBIO’s [@Biotechnology] market capitalization is $106.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CALC’s FA Score shows that 2 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • CALC’s FA Score: 2 green, 3 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, CALC is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CALC’s TA Score shows that 4 TA indicator(s) are bullish while OBIO’s TA Score has 5 bullish TA indicator(s).

  • CALC’s TA Score: 4 bullish, 6 bearish.
  • OBIO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, OBIO is a better buy in the short-term than CALC.

Price Growth

CALC (@Biotechnology) experienced а +0.64% price change this week, while OBIO (@Biotechnology) price change was -6.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +33.16%, and the average quarterly price growth was +1.56%.

Reported Earning Dates

CALC is expected to report earnings on May 14, 2025.

OBIO is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OBIO($106M) has a higher market cap than CALC($21.9M). OBIO YTD gains are higher at: -30.750 vs. CALC (-55.367). CALC has higher annual earnings (EBITDA): -28.87M vs. OBIO (-68.48M). OBIO has more cash in the bank: 49.9M vs. CALC (24.6M). CALC has less debt than OBIO: CALC (8.6M) vs OBIO (16.4M). OBIO has higher revenues than CALC: OBIO (2.89M) vs CALC (0).
CALCOBIOCALC / OBIO
Capitalization21.9M106M21%
EBITDA-28.87M-68.48M42%
Gain YTD-55.367-30.750180%
P/E Ratio0.30N/A-
Revenue02.89M-
Total Cash24.6M49.9M49%
Total Debt8.6M16.4M52%
TECHNICAL ANALYSIS
Technical Analysis
CALCOBIO
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
58%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 23 days ago
78%
Bullish Trend 9 days ago
60%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 3 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
56%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PAUIF0.860.06
+7.84%
PREMIER AMERICAN URANIUM INC.
DSHK0.10N/A
+1.24%
Drive Shack Inc.
NVZMY72.000.36
+0.50%
NOVONESIS A S
CRDE16007.00N/A
N/A
Cardinal Ethanol LLC
SHALY10.76N/A
N/A
Shangri-La Asia Ltd.

CALC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CALC has been loosely correlated with IMMP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CALC jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALC
1D Price
Change %
CALC100%
+1.28%
IMMP - CALC
38%
Loosely correlated
+3.66%
OBIO - CALC
33%
Poorly correlated
+3.97%
THAR - CALC
32%
Poorly correlated
+2.25%
ALDX - CALC
26%
Poorly correlated
+1.53%
VTYX - CALC
26%
Poorly correlated
-2.66%
More

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with GBIO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
+3.36%
GBIO - OBIO
39%
Loosely correlated
-0.03%
XERS - OBIO
39%
Loosely correlated
-0.21%
ABEO - OBIO
38%
Loosely correlated
-1.94%
OCUL - OBIO
38%
Loosely correlated
-1.94%
GLSI - OBIO
38%
Loosely correlated
-0.22%
More